Articles published by Gain Therapeutics, Inc.
Gain Therapeutics to Participate at Upcoming Investor Conferences
October 03, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
August 08, 2024
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
March 26, 2024
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight
February 14, 2024
Via GlobeNewswire
Tickers
GANX
UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
February 06, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
February 06, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
January 31, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research
December 04, 2023
Via GlobeNewswire
Tickers
GANX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.